EOS risk categories | Included patients |
---|---|
High-risk patients | ≥ 34 weeks’ GA neonates with birth weight ≤ 1500 g |
34–36 weeks’ GA neonates with suspected intraamniotic infection | |
≥ 34 weeks’ GA neonates with three clinical signs of EOS | |
≥ 34 weeks’ GA neonates with two clinical signs and one risk factor for EOS | |
Medium-risk patients | 34 weeks’ GA neonates without suspicion of intraamniotic infection |
≥ 35 weeks’ GA neonates from mothers with previous infant affected by invasive GBS disease and inadequate IAPa | |
≥ 35 weeks’ GA neonates from mothers with GBS bacteriuria during any trimester of the current pregnancy and inadequate IAP (not if a cesarean delivery is performed before onset of labor on a woman with intact amniotic membranes)a | |
≥ 35 weeks’ GA neonates from mothers with positive GBS vaginal-rectal screening culture within 5 weeks before delivery and inadequate IAP (not if a cesarean delivery is performed before onset of labor on a woman with intact amniotic membranes)a | |
35–36 weeks’ GA neonates with unknown GBS maternal status at the onset of labor and inadequate IAP (not if a cesarean delivery is performed before onset of labor on a woman with intact amniotic membranes)a | |
≥ 35 weeks’ GA neonates from mothers with amniotic membrane rupture ≥18 h and inadequate IAPa | |
35–36 weeks’ GA neonates from mothers with intrapartum temperature ≥ 38.0 °C | |
≥ 37 weeks’ GA neonates with suspected intraamniotic infection and inadequate IAPa | |
≥ 37 weeks’ GA neonates with maternal intrapartum temperature ≥ 38.0 °C and inadequate IAPa | |
≥ 34 weeks’ GA neonates with one or two clinical indicators of EOS | |
Low-risk patients | Well-appearing neonates ≥34 weeks’ GA with no risk factors for EOS |